For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
ProCare says new funding for cancer screening a life-saving move for women
ProCare says new funding for cancer screening a life-saving move for women

New Zealand’s largest Primary Health Organisation (PHO), ProCare, is delighted with the announcement from Associate Health Minister Dr Ayesha Verrall that the Government will commit $53 million in Budget 2021 to support the introduction of new cancer screening for women, including the introduction of the easier self-screen test for HPV.
ProCare CEO Bindi Norwell said “it is fantastic to see the Government commit additional funding to initiatives that support better health outcomes for women. We have been advocating for the introduction of the self-test for HPV to improve screening for cervical cancer as we know through our General Practice network that the traditional smear test is something many women feel uncomfortable about, espeically Māori and Pacific whānau. The introduction of this simple test will save lives as well as improve the experiences women have when engaging with their General Practice.”